News For Biogen Idec


This RSS feed URL is deprecated

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google 11/16/2018 2:28:33 PM

Global Neurodegenerative Disease Market 2018 – Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB - Chemical News 24 (press release) (blog)


Chemical News 24 (press release) (blog)

Global Neurodegenerative Disease Market 2018 – Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB
Chemical News 24 (press release) (blog)
The research report review on Global Neurodegenerative Disease Market provides important information about key driving forces, restraints, Business Intelligence opportunities, threats and challenges in the competitive Business Intelligence market.

and more »
Google 11/16/2018 9:15:01 AM

Biosimilars/Follow-on-Biologics Market 2018-2023 Growth Rate, Manufacturers, Market Shares, Sales, Production ... - Tactical Business


Biosimilars/Follow-on-Biologics Market 2018-2023 Growth Rate, Manufacturers, Market Shares, Sales, Production ...
Tactical Business
Top Players in Biosimilars/Follow-on-Biologics market are Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group, Biogen idec; Inc., Genentech (Roche Group). Geographical Regions ...

and more »
Google 11/16/2018 5:04:23 AM


Global Iv Fluid Transfer Drugs Devices Market 2018- Novartis International AG, Emerade, Biogen Idec Inc, ALK Abello ... - Technology Gazette


Technology Gazette

Global Iv Fluid Transfer Drugs Devices Market 2018- Novartis International AG, Emerade, Biogen Idec Inc, ALK Abello ...
Technology Gazette
Global Iv Fluid Transfer Drugs Devices Market Report especially enfolds the detailed insight of numerous aspects and estimations of Iv Fluid Transfer Drugs Devices market for the period of 2018 to 2023. The report is a compilation of significant ...
GRN RESEARCH PVT LTD | LinkedInLinkedIn

all 25 news articles »
Google 11/15/2018 12:43:18 PM


Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success - Genetic Engineering & Biotechnology News


Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
Genetic Engineering & Biotechnology News
The new collaboration builds on the partnership launched in 2012 by Biogen and Ionis, back when they were known as Biogen Idec and Isis Pharmaceuticals, respectively. That partnership advanced Spinraza through clinical phases to FDA approval in ...

Google 11/4/2018 3:26:13 PM

Colgate-Palmolive, Biogen Idec, Covanta: 'Mad Money' Lightning Round - TheStreet.com


TheStreet.com

Colgate-Palmolive, Biogen Idec, Covanta: 'Mad Money' Lightning Round
TheStreet.com
Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round: Colgate-Palmolive (CL - Get Report) : "They did not have a good quarter but when the yield hits 3.5%, I'd buy it." Biogen Idec (BIIB - Get Report) : "I ...

and more »
Google 11/2/2018 12:40:16 AM

 1 2